Airway Inflammation in Swimmers

Sponsor
Bispebjerg Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT00207038
Collaborator
Imperial College London (Other), Sygekassernes Helsefond (Other), Toyota-Fonden (Other), Team Denmark (Other), Anti Doping Danmark (Other), Ragnhild Ibsens Legat For Medicinsk Forskning (Other), Kong Christian IX og Dronning Louises Jubilæumslegat (Other), Kong Christian den Tiendes Fond (Other)
90
1
41
2.2

Study Details

Study Description

Brief Summary

Studies have shown that the prevalence of respiratory symptoms, airway hyperresponsiveness (AHR) and asthma is high and increasing in elite athletes. The inflammation seen in the airways of elite athletes might differ from the inflammation seen in the airways of "ordinary" asthmatics and it might represent a different kind of asthma.

The primary purposes are

  1. To investigate the type of airway inflammation in young swimmers.

  2. To investigate the acute changes in airway inflammation after a short training session.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    90 participants
    Observational Model:
    Cohort
    Time Perspective:
    Cross-Sectional
    Official Title:
    Airway Inflammation in Swimmers: Development and Risk Factors
    Study Start Date :
    Sep 1, 2005
    Actual Study Completion Date :
    Feb 1, 2009

    Outcome Measures

    Primary Outcome Measures

      Eligibility Criteria

      Criteria

      Ages Eligible for Study:
      10 Years to 16 Years
      Sexes Eligible for Study:
      All
      Accepts Healthy Volunteers:
      Yes
      Inclusion Criteria:
      • Swimmer
      Exclusion Criteria:
      • Current smoker or more than 3 pack-years

      Contacts and Locations

      Locations

      Site City State Country Postal Code
      1 Respiratory and Allergy Research Unit, Department of Internal Medicine, Bispebjerg Hospital, University Hospital of Copenhagen Copenhagen Denmark 2400

      Sponsors and Collaborators

      • Bispebjerg Hospital
      • Imperial College London
      • Sygekassernes Helsefond
      • Toyota-Fonden
      • Team Denmark
      • Anti Doping Danmark
      • Ragnhild Ibsens Legat For Medicinsk Forskning
      • Kong Christian IX og Dronning Louises Jubilæumslegat
      • Kong Christian den Tiendes Fond

      Investigators

      • Study Chair: Lars Pedersen, MD, Respiratory and Allergy Reseach Unit, Department of Internal Medicine, Bispebjerg Bakke 23, Bispebjerg Hospital, University Hospital of Copenhagen, DK-2400 Copenhagen NV, Denmark

      Study Documents (Full-Text)

      None provided.

      More Information

      Publications

      None provided.
      Responsible Party:
      , ,
      ClinicalTrials.gov Identifier:
      NCT00207038
      Other Study ID Numbers:
      • (KF) 01 261528
      First Posted:
      Sep 21, 2005
      Last Update Posted:
      Feb 11, 2009
      Last Verified:
      Feb 1, 2009
      Keywords provided by , ,
      Additional relevant MeSH terms:

      Study Results

      No Results Posted as of Feb 11, 2009